ストックスクリーナーアプリを入手
24.86
2.35%
0.57
Seaport Therapeutics Inc (SPTX) 最新ニュース
symbol__ Stock Quote Price and Forecast - CNN
Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO - 24/7 Wall St.
Seaport Therapeutics' (SPTX) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Seaport Therapeutics stock rating at buy By Investing.com - Investing.com Canada
Selvaraju Reiterates Buy on Seaport, Citing Differentiated Neuropsychiatry Pipeline and Unchanged $50 Price Target - TipRanks
Trv Gp Vi LLC Purchases New Holdings in Seaport Therapeutics, Inc. $SPTX - MarketBeat
Seaport Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SPTX | US81221K1088 - marketscreener.com
Seaport Therapeutics (NASDAQ:SPTX) Reaches New 52-Week HighHere's What Happened - MarketBeat
Seaport Therapeutics Inc. (SPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
PureTech Health (SPTX holder) discloses 31.2% Seaport Therapeutics stake - Stock Titan
Seaport Therapeutics, Inc. Common Stock (NASDAQ: SPTX) Stock Price, News & Analysis - kalkine.com.au
Stifel Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Top Seaport Therapeutics (SPTX) Competitors 2026 - MarketBeat
Seaport Therapeutics (SPTX) Stock Chart and Price History 2026 - MarketBeat
Seaport Therapeutics: A Development-Arbitrage Platform With Two Layers Of Validation - Seeking Alpha
Seaport Therapeutics (SPTX) Institutional Ownership 2026 - MarketBeat
Seaport Therapeutics, Inc. (NASDAQ:SPTX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Seaport Therapeutics (NASDAQ:SPTX) Sets New 52-Week HighTime to Buy? - MarketBeat
HC Wainwright Has Negative Outlook for SPTX FY2026 Earnings - MarketBeat
Analysts’ Top NA Picks: Ceribell, Inc. (CBLL), Ethos Technologies Inc. Class A (LIFE) - The Globe and Mail
Seaport Therapeutics (SPTX): Daphne Zohar discloses 5.23M-share, 9.1% beneficial stake - Stock Titan
Seaport Therapeutics (SPTX) insider Steven M. Paul reports 6.3% stake - stocktitan.net
Seaport Therapeutics Reaffirmed at Buy as Clinical Pipeline Advances and $50 Price Target Remains Unchanged - TipRanks
Citi Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35 - Moomoo
H.C. Wainwright Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $50 - Moomoo
Seaport Therapeutics (NASDAQ:SPTX) Given Buy Rating at HC Wainwright - MarketBeat
Seaport Therapeutics, Inc. 2026 Q2 Financials: Forward-Looking Statements, Risks, and Company Highlights - Minichart
Seaport Therapeutics 2Q Research and Development Expenses Were $24.6M >SPTX - Moomoo
Seaport Therapeutics reports Q2 2026 net loss $62.6M, $427.3M cash; advances GlyphAllo and GlyphAgo - TradingView
Earnings Flash (SPTX) Seaport Therapeutics Posts Q2 Loss $1.78 a Share - marketscreener.com
Seaport Therapeutics, Inc. 2Q 2026: Revenue $0 Net loss $(62.6)M, EPS $(1.78) — 10-Q Summary - TradingView
Seaport Therapeutics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - Yahoo Finance
Seaport Therapeutics, Inc. Revenue Breakdown – NASDAQ:SPTX - TradingView
SPTX Price Today: Seaport Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC
Seaport Therapeutics (SPTX) Earnings Date and Reports 2026 - MarketBeat
Michael Cunyuan Chen Net Worth (2026) - GuruFocus
Seaport Therapeutics, Inc. Revenue Breakdown – BOATS:SPTX - TradingView
Lana Gladstein Net Worth (2026) - GuruFocus
Enterprise value to EBITDA forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Q2 Earnings Forecast for SPTX Issued By HC Wainwright - MarketBeat
Seaport Therapeutics (NASDAQ:SPTX) Stock Rating Upgraded by HC Wainwright - MarketBeat
Seaport Therapeutics stock initiated at buy by H.C. Wainwright - Investing.com Canada
Seaport Therapeutics, Inc. (NASDAQ:SPTX) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress - AOL.com
Wolfe Research Initiates Seaport Therapeutics(SPTX.US) With Hold Rating - Moomoo
Price to earnings forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Price to sales forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
SPTX Forecast — Price Target — Prediction for 2027 - TradingView
Seaport Therapeutics, Inc. Actuals & Estimates (NASDAQ:SPTX) - TradingView
Price to book forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Enterprise value to EBIT forward of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):